BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25894030)

  • 1. Cost-effectiveness of statins in older adults: further evidence that less is more.
    Rich MW
    Ann Intern Med; 2015 Apr; 162(8):590-1. PubMed ID: 25894030
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins for primary prevention in older adults.
    Ann Intern Med; 2015 Apr; 162(8):I-28. PubMed ID: 25894041
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States.
    Odden MC; Pletcher MJ; Coxson PG; Thekkethala D; Guzman D; Heller D; Goldman L; Bibbins-Domingo K
    Ann Intern Med; 2015 Apr; 162(8):533-41. PubMed ID: 25894023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins for Primary Prevention in Adults Aged 75 Years or Older.
    Odden MC; Goldman L; Bibbins-Domingo K
    Ann Intern Med; 2015 Sep; 163(6):482. PubMed ID: 26370015
    [No Abstract]   [Full Text] [Related]  

  • 5. Statins for Primary Prevention in Adults Aged 75 Years or Older.
    Reidenberg MM
    Ann Intern Med; 2015 Sep; 163(6):481. PubMed ID: 26370014
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins for Primary Prevention in Adults Aged 75 Years or Older.
    Robinson JG
    Ann Intern Med; 2015 Sep; 163(6):481. PubMed ID: 26370013
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins for the primary prevention of cardiovascular disease in women?
    Birge SJ
    Menopause; 2012 Dec; 19(12):1287-8. PubMed ID: 23187611
    [No Abstract]   [Full Text] [Related]  

  • 8. [Statins in primary prevention - a must for the general practitioner?].
    Zoller M
    Praxis (Bern 1994); 2011 Jul; 100(14):859-60. PubMed ID: 21732299
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands.
    de Vries FM; Denig P; Visser ST; Hak E; Postma MJ
    Value Health; 2014 Mar; 17(2):223-30. PubMed ID: 24636380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary prevention of cardiovascular disease with statin in type 2 diabetes mellitus: Is it time to change our strategy?].
    Albert Fàbregas L; González-Clemente JM
    Med Clin (Barc); 2014 Apr; 142(8):358-9. PubMed ID: 24602748
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins for the primary prevention of cardiovascular disease.
    Ebrahim S; Taylor FC; Brindle P
    BMJ; 2014 Jan; 348():g280. PubMed ID: 24470636
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: a French adaptation of CARDS.
    Lafuma A; Colin X; Solesse A
    Arch Cardiovasc Dis; 2008 May; 101(5):327-32. PubMed ID: 18656091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of drug treatments for primary prevention of cardiovascular disease: a modelling study.
    Marshall T
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):523-8. PubMed ID: 16874140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases.
    Corrao G; Scotti L; Zambon A; Baio G; Nicotra F; Conti V; Capri S; Tragni E; Merlino L; Catapano AL; Mancia G
    Atherosclerosis; 2011 Aug; 217(2):479-85. PubMed ID: 21592477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins for Primary Prevention of Cardiovascular Disease: Review of Evidence and Recommendations for Clinical Practice.
    Kazi DS; Penko JM; Bibbins-Domingo K
    Med Clin North Am; 2017 Jul; 101(4):689-699. PubMed ID: 28577620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of primary and secondary prevention in cardiovascular diseases.
    Troche CJ; Tacke J; Hinzpeter B; Danner M; Lauterbach KW
    Eur Heart J; 1998 Apr; 19 Suppl C():C59-65. PubMed ID: 9597427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How far the rates of cholesterol have to be lowered in primary prevention?].
    Rodondi N
    Rev Med Suisse; 2010 Mar; 6(239):483-4. PubMed ID: 20373693
    [No Abstract]   [Full Text] [Related]  

  • 18. Statins for primary prevention in older adults: who is high risk, who is old, and what denotes primary prevention?
    Zieman SJ; Ouyang P
    Ann Intern Med; 2010 Apr; 152(8):528-30, W183. PubMed ID: 20404384
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescribing statins in general practice: who decides?
    Steel N; Fleetcroft B; Hassan Y
    Br J Gen Pract; 2017 Jun; 67(659):246-247. PubMed ID: 28546390
    [No Abstract]   [Full Text] [Related]  

  • 20. Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence.
    Gurwitz JH; Go AS; Fortmann SP
    JAMA; 2016 Nov; 316(19):1971-1972. PubMed ID: 27838724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.